A carregar...
Lipid Metabolism in Late-Onset Alzheimer’s Disease Differs from Patients Presenting with Other Dementia Phenotypes
Abnormal cerebrospinal fluid (CSF) levels of β-amyloid peptides (Aβ(42)) and Tau and cognitive decline are typical characteristics of Alzheimer’s disease (AD). Since dysregulation in lipid metabolism accompanies abnormal amyloid formation, we quantified glycerophospholipids (GP) and sphingolipids (S...
Na minha lista:
| Publicado no: | Int J Environ Res Public Health |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6603882/ https://ncbi.nlm.nih.gov/pubmed/31195602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph16111995 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|